malignancy and psoriatic arthritis Archives

Abstract Number: 1595 • ACR/ARHP Annual Meeting 2018
Malignancy in Psoriatic Disease
Anastasiya Muntyanu¹, Ker-Ai Lee², Justine Y. Ye³, Ari Polachek³, Vinod Chandran⁴, Richard J. Cook² and Dafna D Gladman¹, ¹University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²Statistics and Actuarial Science, University of Waterloo, Waterloo, ON, Canada, ³Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ⁴Medicine, Krembil Research Institute, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada
Background/Purpose: There are conflicting data between studies of psoriasis and psoriatic arthritis (PsA), and there have been recent concerns about the potential of anti-TNF agents…
Abstract Number: 1684 • ACR/ARHP Annual Meeting 2015
Malignancies in Patients with Incident Psoriatic Arthritis 1970-2008 in Relation to a Comparator Cohort: A Population-Based Case-Control Study
Katelynn Wilton^1,2, Brittny T. Major³, Cynthia Crowson³ and Eric L. Matteson⁴, ¹Medical Scientist Training Program, Mayo Clinic, Rochester, MN, ²Medical Scientist Training Program, Mayo Clinic Rochester, Rochester, MN, ³Biostatistics, Mayo Clinic, Rochester, MN, ⁴Rheumatology, Mayo Clinic, Rochester, MN
Background/Purpose: In psoriatic arthritis (PsA), misdirected inflammation and therapeutic use of immunosuppressants causes global immune compromise. Similar immunocompromised states, as in rheumatoid arthritis and psoriasis…
Abstract Number: 1849 • ACR/ARHP Annual Meeting 2014
Risk of Malignancy Among Medicare Psoriasis/Psoriasis Arthritis Patients
Huifeng Yun¹, Kevin L. Winthrop², Lang Chen³, Wilson Smith⁴, Benjamin Chan⁵, Fenglong Xie⁶, Allison Taylor⁴ and Jeffrey R. Curtis⁷, ¹Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, AL, ²Dept of Infectious Disease, Oregon Health & Science University, Portland, OR, ³Medicine, University of Alabama at Birmingham, Birmingham, AL, ⁴Clinical Immunology/Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁵Oregon Health and Science University, Portland, OR, ⁶Rheumatology & Immunology, University of Alabama at Birmingham, Birmingham, AL, ⁷University of Alabama at Birmingham, Birmingham, AL
Background/Purpose The introduction of biologics has greatly changed the treatment of psoriatic arthritis (PsA) and psoriasis (PsO). However, there are concerns regarding the risk of…

Abstracts tagged "malignancy and psoriatic arthritis"

Malignancy in Psoriatic Disease

Malignancies in Patients with Incident Psoriatic Arthritis 1970-2008 in Relation to a Comparator Cohort: A Population-Based Case-Control Study

Risk of Malignancy Among Medicare Psoriasis/Psoriasis Arthritis Patients